• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越结构:利用组学方法定义肠道功能以进行个性化治疗的合理设计

Beyond Structure: Defining the Function of the Gut Using Omic Approaches for Rational Design of Personalized Therapeutics.

作者信息

Theriot Casey M

机构信息

Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.

出版信息

mSystems. 2018 Mar 6;3(2). doi: 10.1128/mSystems.00173-17. eCollection 2018 Mar-Apr.

DOI:10.1128/mSystems.00173-17
PMID:29556548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853185/
Abstract

Over the past 10 years, microbiome research has focused on defining the structures associated with different disease states in multiple systems, but has fallen short on showing causation. Prior omic studies have generated many new hypotheses, but moving forward we need to start dissecting the function of each bacterium alone and in concert with complex bacterial communities in well-characterized systems. Over the next 5 years, we need a merging of new omic technologies for exploratory studies with classical bacterial genetics, bacterial physiology, protein engineering, and biochemistry to further define the biochemical mechanisms of the gut microbiota. The future of the systems microbiology field will focus on targeted engineering and editing of the microbiome to alter function, which will be leveraged to prevent and/or treat human diseases. This perspective will focus on my contribution to the microbiome field, both past and present, and where I think research in the field is headed in the near future.

摘要

在过去十年中,微生物组研究主要集中在确定多个系统中与不同疾病状态相关的结构,但在证明因果关系方面有所欠缺。先前的组学研究提出了许多新的假设,但展望未来,我们需要开始剖析每种细菌单独以及与特征明确的系统中的复杂细菌群落协同发挥的功能。在接下来的五年里,我们需要将用于探索性研究的新组学技术与经典细菌遗传学、细菌生理学、蛋白质工程和生物化学相结合,以进一步明确肠道微生物群的生化机制。系统微生物学领域的未来将聚焦于对微生物组进行靶向工程改造和编辑以改变其功能,这将被用于预防和/或治疗人类疾病。这篇观点文章将聚焦于我过去和现在对微生物组领域的贡献,以及我认为该领域在不久的将来的研究方向。

相似文献

1
Beyond Structure: Defining the Function of the Gut Using Omic Approaches for Rational Design of Personalized Therapeutics.超越结构:利用组学方法定义肠道功能以进行个性化治疗的合理设计
mSystems. 2018 Mar 6;3(2). doi: 10.1128/mSystems.00173-17. eCollection 2018 Mar-Apr.
2
Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine.抗生素诱导的肠道微生物群改变会改变次级胆汁酸的产生,并允许艰难梭菌孢子在大肠中发芽和生长。
mSphere. 2016 Jan 6;1(1). doi: 10.1128/mSphere.00045-15. eCollection 2016 Jan-Feb.
3
The potential impact of gut microbiota on your health:Current status and future challenges.肠道微生物群对健康的潜在影响:现状与未来挑战。
Asian Pac J Allergy Immunol. 2016 Dec;34(4):249-264. doi: 10.12932/AP0803.
4
Systems biology perspective for studying the gut microbiota in human physiology and liver diseases.从系统生物学角度研究肠道微生物群在人类生理学和肝脏疾病中的作用。
EBioMedicine. 2019 Nov;49:364-373. doi: 10.1016/j.ebiom.2019.09.057. Epub 2019 Oct 18.
5
Delivery to the gut microbiota: A rapidly proliferating research field.递送至肠道微生物群:一个快速增殖的研究领域。
Adv Colloid Interface Sci. 2019 Dec;274:102038. doi: 10.1016/j.cis.2019.102038. Epub 2019 Oct 18.
6
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity.糖尿病与肥胖症中的肠道微生物群、宿主生物体和饮食三方对话
Front Nutr. 2019 Mar 13;6:21. doi: 10.3389/fnut.2019.00021. eCollection 2019.
7
Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.抗生素诱导的小鼠肠道微生物群改变及其对艰难梭菌定植抗性的后续影响。
mBio. 2015 Jul 14;6(4):e00974. doi: 10.1128/mBio.00974-15.
8
Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality?肥胖与代谢异常中的肠道微生物群:与组成或功能有关?
Arch Med Res. 2017 Nov;48(8):735-753. doi: 10.1016/j.arcmed.2017.11.003. Epub 2017 Dec 29.
9
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.肠道微生物群作为2型糖尿病高血糖预防和治疗的靶点:从当前的人类证据到未来的可能性
Diabetologia. 2017 Jun;60(6):943-951. doi: 10.1007/s00125-017-4278-3. Epub 2017 Apr 22.
10
Human distal gut microbiome.人类远端肠道微生物组。
Environ Microbiol. 2011 Dec;13(12):3088-102. doi: 10.1111/j.1462-2920.2011.02574.x. Epub 2011 Sep 12.

引用本文的文献

1
Differential View on the Bile Acid Stress Response of .关于……胆汁酸应激反应的不同观点
Front Microbiol. 2019 Feb 18;10:258. doi: 10.3389/fmicb.2019.00258. eCollection 2019.
2
Probiotic Product Enhances Susceptibility of Mice to Cryptosporidiosis.益生菌产品增强了小鼠对隐孢子虫病的易感性。
Appl Environ Microbiol. 2018 Oct 17;84(21). doi: 10.1128/AEM.01408-18. Print 2018 Nov 1.

本文引用的文献

1
Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics.食品级乳杆菌的基因组编辑以开发治疗性益生菌。
Microbiol Spectr. 2017 Sep;5(5). doi: 10.1128/microbiolspec.BAD-0013-2016.
2
New class of precision antimicrobials redefines role of S-layer in virulence and viability.新型精准抗菌药物重新定义了 S 层在毒力和生存能力中的作用。
Sci Transl Med. 2017 Sep 6;9(406). doi: 10.1126/scitranslmed.aah6813.
3
An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.人类肠道微生物群中β-葡萄糖醛酸酶图谱
Structure. 2017 Jul 5;25(7):967-977.e5. doi: 10.1016/j.str.2017.05.003. Epub 2017 Jun 1.
4
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.用头孢哌酮治疗的具有临床相关性的艰难梭菌菌株R20291小鼠模型。
J Vis Exp. 2016 Dec 10(118):54850. doi: 10.3791/54850.
5
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility.缺乏膳食纤维的肠道微生物群会破坏结肠黏液屏障并增加对病原体的易感性。
Cell. 2016 Nov 17;167(5):1339-1353.e21. doi: 10.1016/j.cell.2016.10.043.
6
A multi-omic future for microbiome studies.微生物组研究的多组学未来。
Nat Microbiol. 2016 Apr 26;1:16049. doi: 10.1038/nmicrobiol.2016.49.
7
Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation.基于代谢模型的微生物群落分类学和代谢组学图谱整合揭示了生态与代谢变化之间的机制联系。
mSystems. 2016 Jan-Feb;1(1). doi: 10.1128/mSystems.00013-15. Epub 2016 Jan 19.
8
Clostridium difficile infection.艰难梭菌感染。
Nat Rev Dis Primers. 2016 Apr 7;2:16020. doi: 10.1038/nrdp.2016.20.
9
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.胃肠道微生物群与艰难梭菌之间的相互作用
Annu Rev Microbiol. 2015;69:445-61. doi: 10.1146/annurev-micro-091014-104115.
10
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.